StockData
VivoSim Labs, INC. logo

VivoSim Labs, INC. (VIVS) stock

VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.12−0.00 (-2.91%)

Close on Nov 17, 2026Market cap $383.64KP/E –Yield –

VivoSim Labs profit margin

Profit margin (net margin) is net income as a percentage of revenue.

VivoSim Labs's profit margin for the twelve months ending Jun 30, 2026 was -11016.1%. For fiscal 2026 it was -10567.2%, against -1727.8% the year before. The highest annual figure on record is -756.1% in fiscal 2018.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2026Mar 31, 2026-10567.2%−8839.4
FY2025Mar 31, 2025-1727.8%+11731.9
FY2024Mar 31, 2024-13459.6%−8795.0
FY2023Mar 31, 2023-4664.6%−3901.4
FY2022Mar 31, 2022-763.2%+88.8
FY2020Mar 31, 2020-852.0%+9.7
FY2019Mar 31, 2019-861.7%−105.6
FY2018Mar 31, 2018-756.1%+152.8
FY2017Mar 31, 2017-908.9%+1692.2
FY2016Mar 31, 2016-2601.1%+2667.2
FY2015Mar 31, 2015-5268.3%−1629.8
FY2012Dec 31, 2012-3638.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ2 2026Jun 30, 2026-7433.3%+250.5
Q4 FY2026CQ1 2026Mar 31, 2026-14410.0%−27845.3
Q3 FY2026CQ4 2025Dec 31, 2025-10350.0%+4012.5
Q2 FY2026CQ3 2025Sep 30, 2025-9089.3%−592.6
Q1 FY2026CQ2 2025Jun 30, 2025-7683.8%+890.6
Q4 FY2025CQ1 2025Mar 31, 202513435.3%+23935.3
Q3 FY2025CQ4 2024Dec 31, 2024-14362.5%+57717.5
Q2 FY2025CQ3 2024Sep 30, 2024-8496.7%−3126.0
Q1 FY2025CQ2 2024Jun 30, 2024-8574.4%−3970.0
Q4 FY2024CQ1 2024Mar 31, 2024-10500.0%−8008.4
Q3 FY2024CQ4 2023Dec 31, 2023-72080.0%−67767.0
Q1 FY2024CQ2 2023Jun 30, 2023-5370.7%−5243.3
Q4 FY2023CQ1 2023Mar 31, 2023-4604.3%−3473.4
Q3 FY2023CQ4 2022Dec 31, 2022-2491.6%−1979.9
Q2 FY2023CQ3 2022Sep 30, 2022-4313.0%−3366.4
Q4 FY2022CQ1 2022Mar 31, 2022-127.4%+899.5
Q3 FY2020CQ4 2019Dec 31, 2019-1130.9%−309.4
Q2 FY2020CQ3 2019Sep 30, 2019-511.7%+107.3
Q1 FY2020CQ2 2019Jun 30, 2019-946.6%+129.8
Q4 FY2019CQ1 2019Mar 31, 2019-1026.9%−352.8
Q3 FY2019CQ4 2018Dec 31, 2018-821.4%−145.7
Q2 FY2019CQ3 2018Sep 30, 2018-619.0%+79.2
Q1 FY2019CQ2 2018Jun 30, 2018-1076.3%−55.9
Q4 FY2018CQ1 2018Mar 31, 2018-674.1%+638.3
Q3 FY2018CQ4 2017Dec 31, 2017-675.7%+156.7
Q2 FY2018CQ3 2017Sep 30, 2017-698.2%−12.0
Q1 FY2018CQ2 2017Jun 30, 2017-1020.4%–
Q4 FY2017CQ1 2017Mar 31, 2017-1312.4%–
Q3 FY2017CQ4 2016Dec 31, 2016-832.4%–
Q2 FY2017CQ3 2016Sep 30, 2016-686.2%–

More VivoSim Labs figures

See a number that looks wrong?